Table 1.
Human and animal PECO (population, exposure, comparator, outcome) statements.
PECO element | Human evidence | Animal evidence |
---|---|---|
Study question | Does developmental exposure to PFOA affect fetal growth in humans? | Does developmental exposure to PFOA affect fetal growth in animals? |
Participants | Humans that are studied during the reproductive/developmental time period (before and/or during pregnancy or development) | Animals from nonhuman species that are studied during the reproductive/developmental time period (before and/or during pregnancy for females or during development for embryos) |
Exposure | Exposure to PFOA (CAS# 335-67-1) or its salts during the time before pregnancy and/or during pregnancy for females or directly to fetuses | One or more oral, subcutaneous, or other treatment(s) of any dosage of PFOA (CAS# 335-67-1) or its salts during the time before pregnancy and/or during pregnancy for females or directly to embryos |
Comparators | Humans exposed to lower levels of PFOA than the more highly exposed humans | Experimental animals receiving different doses of PFOA or vehicle-only treatment |
Outcomes | Effects on fetal growth, birth weight, and/or other measures of size, such as length | Changes in fetal weight near term (e.g., embryonic day 18 for mice, embryonic day 21 for rats), birth weight, and/or other measures of size at term or birth, such as length |